BCP Investment: Q3 Earnings Snapshot

BCP Investment Corp. reported a Q3 loss of $13.5M ($1.09 per share), down from a profit last year. Adjusted earnings were 37 cents per share on $13.9M revenue. Shares have fallen 44% YTD and 49% over 12 months, closing at $6.57 on Wednesday.

Original reporting
Published Nov 11, 2026, 11:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 11:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BCP Investment: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$BCICBearishMed
01

Why it matters

The earnings miss may trigger short‑covering and sell pressure, but the stock's prior decline suggests limited upside.

02

Market read

Earnings release for a micro‑cap BDC; relevant for traders focused on small‑cap earnings volatility.

03

What to watch

Potential upcoming capital raise or asset sales not disclosed yet could mitigate downside.

Relevance 6/10Novelty 6/10Timing: after‑hours reaction

Background

BCP Investment Corp. is a publicly traded business‑development company that posted a quarterly loss after a profit year‑ago.

Company-level read

Ticker impact

$BCICBearishHigh confidence
Context

BCIC reported a Q3 loss of $13.5M and a loss per share of $1.09, the first earnings release for the quarter.

Expected impact

likely downward pressure as investors price in the loss

Evidence & confidence

Earnings miss with a sizable share price decline since year‑start signals weak performance.

Market effects

Highlights weakness in the business‑development‑company sector, may affect peer valuations.

Primarily U.S. market impact; limited broader regional effect.

Minimal global relevance beyond niche investors.

Counterpoint

If the loss is viewed as a one‑time adjustment, the stock could be undervalued.

Key entities

  • BCP Investment Corp.

    Business‑development company reporting Q3 results.

Related articles

$BCICMed

BCP Investment Corp (BCIC) (Q2 2026) Earnings Call Highlights: NAV Declines

BCP Investment Corp (BCIC) reported Q2 2026 results on an earnings call. NAV fell to $14.49 per share from $15.60, driven by unrealized mark-to-market declines concentrated in software. Investment income dropped to $15.2M from $17.6M, and the company recorded a $10.5M realized loss from resolving two non-accrual positions. Net leverage rose to 1.6x. CEO Ted Goldthorpe said buybacks are preferred over new deals given the stock’s discount to NAV.

$NEONMed

Neonode Reports Quarter Ended September 30, 2026 Financial Results

Neonode Inc. (NEON) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Press Release For Release, 9:10AM ET November 12, 2026 Neonode Reports Quarter Ended September 30, 2026 Financial Results STOCKHOLM, SWEDEN, November 12, 2026 — Neonode Inc. (NASDAQ: NEON) (“Neonode” or the “Company”) today reported financial results for the three an

$UGMed

United-Guardian 3Q 2026: Revenue $3.49M, EPS $0.2 — 10-Q Summary

United-Guardian reported 3Q 2026 revenue of $3.49M, up 54% YoY, with EPS of $0.2. Growth was driven by pharmaceuticals, cosmetic ingredients, and medical lubricants. Pharmaceutical sales rose 29% due to Renacidin formulary coverage, while cosmetic ingredient sales climbed 187% after ASI resumed purchases. Medical lubricant sales increased 20%, and cost of sales fell to 46% of revenue.

$CLBTHighAI 9/10

Why is Cellebrite stock surging today?

Cellebrite's stock rose 5.9% in pre-market trading after Q3 2026 results beat expectations, with non-GAAP EPS of $0.17 vs. $0.10 consensus. Annual recurring revenue grew 20% YoY to $528.5M. The company raised its 2026 adjusted EBITDA outlook to $163M-$166M. CEO Shiv Ramji cited strong international and U.S. Federal performance. Operating cash flow increased 70% to $56.58M.